Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- MANTRAIndependent statistical analysis of Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04979442).
- MAP-PAFIndependent statistical analysis of Ablation of the Pulmonary Veins for Paroxysmal Afib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00744874).
- MAP-XIndependent statistical analysis of Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MAPSIndependent statistical analysis of MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01411345).
- Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Marijuana in Combination With Opioids in Palliative and Hospice Patients: Complete Statistical AnalysisIndependent statistical analysis of Marijuana in Combination With Opioids in Palliative and Hospice Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03233633).
- MARINAIndependent statistical analysis of Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MARINOLIndependent statistical analysis of Dronabinol Treatment for Marijuana Addiction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00217971).
- MARLINA – T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin: Complete Statistical AnalysisIndependent statistical analysis of MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin: primary endpoint results, effect estimate with confidence interval,…
- MARRSIndependent statistical analysis of Millipede AspiRation for Revascularization in Stroke (MARRS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05714501).
- MARSIndependent statistical analysis of Project MARS: Mobile-Assistance for Regulating Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04376489).
- MASCIndependent statistical analysis of MASC: Reducing Stress for Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05847153).
- MASCIIndependent statistical analysis of Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MASHIndependent statistical analysis of Manual Therapy and Strengthening for the Hip in Older Adults With Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MASS2Independent statistical analysis of Micra Accelerometer Sensor Study 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02930980).
- Massive Iron Deposit Assessment: Complete Statistical AnalysisIndependent statistical analysis of Massive Iron Deposit Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01572922).
- Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE: Complete Statistical AnalysisIndependent statistical analysis of Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MASTIndependent statistical analysis of MAST Trial: Multi-modal Analgesic Strategies in Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03472469).
- MASTIndependent statistical analysis of Study of the Mechanisms of Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00595153).
- Master Study for the Investigation of Safety and Efficacy of the EVIA Pacemaker: Complete Statistical AnalysisIndependent statistical analysis of Master Study for the Investigation of Safety and Efficacy of the EVIA Pacemaker: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MasterKey-01Independent statistical analysis of A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MASTERKEY-265Independent statistical analysis of Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02263508).
- MASTERSIndependent statistical analysis of Maintaining Suppression of Testosterone With Transdermal Estradiol Gel: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02349386).
- MATADORSIndependent statistical analysis of Managing AsThma AnD Obesity Related Symptoms (MATADORS) Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05742646).
- MATCh-GDMIndependent statistical analysis of Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03029702).
- Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Maternal Role in Oral Feed Establishment in Preterm Neonates: Complete Statistical AnalysisIndependent statistical analysis of Maternal Role in Oral Feed Establishment in Preterm Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05484726).
- MATOCSSIndependent statistical analysis of Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MATRIX-2Independent statistical analysis of Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mature B-Cell Lymphoma And Leukemia Study III: Complete Statistical AnalysisIndependent statistical analysis of Mature B-Cell Lymphoma And Leukemia Study III: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01046825).
- MAVANIndependent statistical analysis of Maternal Adversity, Vulnerability and Neurodevelopment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03434457).
- MAVERICIndependent statistical analysis of Maraviroc Efficacy for Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02881762).
- MAVERICK-HCMIndependent statistical analysis of A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MAVISIndependent statistical analysis of Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation: Complete Statistical AnalysisIndependent statistical analysis of Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Maxigesic IV Phase 3 Bunionectomy Study: Complete Statistical AnalysisIndependent statistical analysis of Maxigesic IV Phase 3 Bunionectomy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02689063).
- Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03098563).
- MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms: Complete Statistical AnalysisIndependent statistical analysis of MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MBKIndependent statistical analysis of Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MBMM+Independent statistical analysis of My Baby My Move A Community Wellness Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04294095).
- MBT+FontanIndependent statistical analysis of Methacetin Breath Test in Patients With Liver Disease Secondary to Heart Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MCAIndependent statistical analysis of Memory & Conditioning Under Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04062123).
- McCAVEIndependent statistical analysis of A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer: primary endpoint results, effect estimate with…
- mCRCIndependent statistical analysis of HepaSphere™ Microspheres Prospective Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04866290).
- MCSIndependent statistical analysis of Evaluation of the Performance of the Motus Cleansing System (MCS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03026075).
- MDDIndependent statistical analysis of The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD): primary endpoint results, effect estimate with confidence interval,…
- MDDCIndependent statistical analysis of Model Driven Diabetes Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01774149).